Insiders · EBS

Robert Kramer

Officer, Director at Emergent BioSolutions Inc. (EBS)

Robert Kramer has filed 12 insider reports with the SEC since January 2021, as officer and director at Emergent BioSolutions Inc. (EBS). Robert Kramer made no open-market purchases or sales in the last 12 months. The latest filing, on June 14, 2023, reports grant or award at Emergent BioSolutions Inc. (EBS).

Filings
12
Companies
1
Bought on market
None
Sold on market
$10.1M

Companies where Robert Kramer is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Emergent BioSolutions Inc. logo
EBS
Emergent BioSolutions Inc.
Officer, Director506,059$10.1M$5.81Jun 14, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert Kramer with

Other insiders at the same companies

Questions about Robert Kramer

What is Robert Kramer's role at Emergent BioSolutions Inc.?
Robert Kramer reports to the SEC as officer and director at Emergent BioSolutions Inc. (EBS), according to the latest filing on June 14, 2023.
How many shares does Robert Kramer own?
After the latest filing that states it, Robert Kramer directly owned 506,059 shares of Emergent BioSolutions Inc. (EBS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert Kramer bought or sold stock recently?
The most recent open-market sale was on February 8, 2021: sold 45,397 shares of Emergent BioSolutions Inc. (EBS) for $5.45M at an average of $120.03.
How do I get alerts when Robert Kramer files?
Follow Robert Kramer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert Kramer (SEC CIK 0001380956). Totals count each trade once, skipping amendments whose original is on file, from Jan 19, 2021 on. View on SEC EDGAR